Psychiatry and Neurology, Neurology · Lexington, KY
NPI
1952857682
Since 2016
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
740 S Limestone, Ste B101
Lexington, KY, 40536
Phone (859) 323-5661
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
346 services
Medicare patients, 2024
204
Average age 70
Drug cost, 2024
$2.1M
2,052 prescriptions
Company payments, 2025
$389
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarek Ali was code 99215 (office e&m - established), 98 times for 84 patients. In total Tarek Ali billed 346 services in 15 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 98 | 84 | $108.41 | $11K |
| 99214 Office E&M - Established | Facility | 72 | 62 | $68.01 | $4,896 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 68 | 37 | $25.03 | $1,702 |
| 99205 Office E&M - New | Facility | 40 | 40 | $135.99 | $5,439 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 15 | $95.51 | $1,910 |
By year: 2022 $29K for 379 services; 2023 $34K for 394 services; 2024 $29K for 346 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tarek Ali prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 477 prescriptions and refills. In total Tarek Ali wrote 2,052 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 477 | 1,177 | 146 | $22K |
| Primidone Generic | 135 | 351 | 45 | $5,940 |
| Clonazepam Generic | 120 | 132 | 28 | $792 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 100 | 267 | 32 | $5,163 |
| Austedo Deutetrabenazine | 85 | 87 | Under 11 | $650K |
| Gabapentin Generic | 74 | 131 | 23 | $1,444 |
| Quetiapine Fumarate Generic | 65 | 166 | 23 | $1,193 |
| Pregabalin Generic | 60 | 82 | 11 | $1,062 |
| Rytary Carbidopa/Levodopa | 54 | 124 | 18 | $126K |
| Donepezil Hcl Generic | 54 | 132 | 20 | $836 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 53 | 126 | 13 | $918 |
| Amantadine Amantadine Hcl | 53 | 119 | 24 | $2,859 |
| Topiramate Generic | 50 | 90 | Under 11 | $559 |
| Levetiracetam Generic | 47 | 91 | 14 | $1,357 |
| Atropine Sulfate Generic | 37 | 49 | 12 | $2,056 |
Brand drugs: 310 claims; generic drugs: 1,742 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarek Ali $389 ($389 in general payments such as food, travel and fees) from 7 companies. The largest payer was Janssen Biotech, Inc. with $159.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.